Atlas Trials

Combination Chemotherapy for Metastatic Breast Cancer

Clinical trial NCT00191815 · COMPLETED

Trial details

NCT number
NCT00191815
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2002-10-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.